Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Frisoni

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|January 7, 2015
Abnormalities in cortical gray matter density in borderline personality disorderR Rossi, M Lanfredi, M Pievani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 22, 2014
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in ItalyB Borroni, R Turrone, D Galimberti, et al.
Neuroimage. Clinical|January 23, 2015
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) studyM Pagani, F De Carli, S Morbelli, et al.
European Journal of Neurology|November 7, 2019
Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patientsM Boccardi, V Nicolosi, C Festari, et al.
Neuroimage. Clinical|May 12, 2019
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)A Chincarini, E Peira, S Morbelli, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
The Journal of Prevention of Alzheimer'S Disease|October 20, 2015
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsE Cavedo, S Lista, Z Khachaturian, et al.
Journal of Internal Medicine|March 5, 2016
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
European Psychiatry : the Journal of the Association of European Psychiatrists|January 7, 2015
Abnormalities in cortical gray matter density in borderline personality disorderR Rossi, M Lanfredi, M Pievani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 22, 2014
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in ItalyB Borroni, R Turrone, D Galimberti, et al.
Neuroimage. Clinical|January 23, 2015
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) studyM Pagani, F De Carli, S Morbelli, et al.
European Journal of Neurology|November 7, 2019
Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patientsM Boccardi, V Nicolosi, C Festari, et al.
Neuroimage. Clinical|May 12, 2019
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)A Chincarini, E Peira, S Morbelli, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
The Journal of Prevention of Alzheimer'S Disease|October 20, 2015
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsE Cavedo, S Lista, Z Khachaturian, et al.
Journal of Internal Medicine|March 5, 2016
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Pageof 20